World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
57
Citations
9058
World Ranking
3636
National Ranking
1429

John F. Modlin publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where John F. Modlin sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 128 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

John F. Modlin D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where John F. Modlin sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 57 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

John F. Modlin is affiliated with the Bill & Melinda Gates Foundation in the United States. The main area of their research is Medicine, with 36 publications contributing to this field. Their work spans diverse subfields including Cardiology and Cardiovascular Medicine, Infectious Diseases, Epidemiology, Immunology, and Pathology and Forensic Medicine.

The scientist has contributed extensively to topics primarily related to viral infections and immunology research. Key topics explored include Viral Infections and Immunology Research, Viral Gastroenteritis Research and Epidemiology, Respiratory Viral Infections Research, Immunodeficiency and Autoimmune Disorders, SARS-CoV-2 and COVID-19 Research, Whipple's Disease and Interleukins, and Animal Virus Infections Studies.

Frequent publication venues for Modlin's work include The Journal of Infectious Diseases, The Lancet, Mucosal Immunology, MMWR Morbidity and Mortality Weekly Report, and The Lancet Infectious Diseases. Specifically, The Journal of Infectious Diseases features four of their publications, reflecting a consistent contribution to this journal.

Recent notable papers by John F. Modlin include:

  • Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials, 2020, The Lancet
  • Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials, 2020, The Lancet
  • Mucosal immunity to poliovirus, 2021, Mucosal Immunology
  • Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication, 2020, The Journal of Infectious Diseases
  • Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021, 2022, MMWR Morbidity and Mortality Weekly Report

Throughout their research career, Modlin has collaborated frequently with other scientists. Notable recurrent coauthors include Ananda S Bandyopadhyay, Ruth I. Connor, Elizabeth B. Brickley, Wendy Wieland-Alter, and Margaret E. Ackerman.

Best Publications

  • Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome.

    Barbara E. Laughon;Barbara E. Laughon;Dolph A. Druckman;Dolph A. Druckman;Andrew Vernon;Andrew Vernon;Thomas C. Quinn;Thomas C. Quinn

  • Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines

    I. M. Onorato;J. F. Modlin;A. M. McBean;M. L. Thoms

  • A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus Disease

    Ross E. McKinney;Mary A. Maha;Edward M. Connor;Judith Feinberg

  • PERINATAL ECHOVIRUS INFECTION: INSIGHTS FROM A LITERATURE REVIEW OF 61 CASES OF SERIOUS INFECTION AND 16 OUTBREAKS IN NURSERIES

    J. F. Modlin

  • Comparative Evaluation of Immunization with Live Attenuated and Enhanced-Potency Inactivated Trivalent Poliovirus Vaccines in Childhood: Systemic and Local Immune Responses

    Howard Faden;John F. Modlin;John F. Modlin;Mary Lou Thoms;Mary Lou Thoms;Alexander M McBean

  • Aseptic Meningitis in Infants <2 Years of Age: Diagnosis and Etiology

    L E Berlin;M L Rorabaugh;F Heldrich;K Roberts

  • Use of anthrax vaccine in the United States: Recommendations of the advisory committee on immunization practices

    J. F. Modlin;Jr Snider;D. A. Brooks;R. D. Clover

  • A fatal central nervous system enterovirus 68 infection.

    Justin D. Kreuter;Arti Barnes;James E. McCarthy;Joseph D. Schwartzman

  • Microbiology of chronic sinusitis in children.

    Peter W. Orobello;Robert I. Park;Laura J. Belcher;Peyton Eggleston

  • Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a Phase I/ii trial

    David Kimberlin;Dwight Powell;William Gruber;Pamela Diaz

  • The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.

    Tami A. Martino;Martin Petric;Hana Weingartl;Jeffrey M. Bergelson

  • Epidemiologic Studies of Measles, Measles Vaccine, and Subacute Sclerosing Panencephalitis

    John F. Modlin;J. T. Jabbour;John J. Witte;Neal A. Halsey

  • First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.

    Linda Harrison;Abdel Babiker;Hannah Castro;Alexandra Compagnucci

  • Treatment of Herpes Simplex Labialis with Topical Acyclovir in Polyethylene Glycol

    S. L. Spruance;L. E. Schnipper;J. C. Overall;E. R. Kern

  • Atypical hand, foot, and mouth disease: a vesiculobullous eruption caused by Coxsackie virus A6

    Henry M Feder;Nicholas Bennett;John F Modlin

  • Vaccine-Associated Paralytic Poliomyelitis:

    Janet L. Beausoleil;Richard E. Nordgren;John F. Modlin

  • The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

    Pierre Van Damme;Ilse De Coster;Ananda S Bandyopadhyay;Hilde Revets

  • Epidemiology of subacute sclerosing panencephalitis

    John F. Modlin;Neal A. Halsey;Donald L. Eddins;J. Lyle Conrad

  • Influence of Maternal Antibodies on Neonatal Immunization against Respiratory Viruses

    James E. Crowe

  • Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors.

    Jeffrey M. Bergelson;John F. Modlin;Wendy Wieland-Alter;Jennifer A. Cunningham

  • Mediastinitis After Cardiovascular Surgery

    David H. Bor;Richard M. Rose;John F. Modlin;Ronald Weintraub

Frequent Co-Authors

Neal A. Halsey
Neal A. Halsey Johns Hopkins University
Mark A. Pallansch
Mark A. Pallansch National Center for Immunization and Respiratory Diseases
Roland W. Sutter
Roland W. Sutter World Health Organization
Robert H. Yolken
Robert H. Yolken Johns Hopkins University
Thomas C. Quinn
Thomas C. Quinn Johns Hopkins University
Robert W. Finberg
Robert W. Finberg University of Massachusetts Chan Medical School
Jeffrey M. Bergelson
Jeffrey M. Bergelson Children's Hospital of Philadelphia
M. Steven Oberste
M. Steven Oberste Centers for Disease Control and Prevention
Ralf Clemens
Ralf Clemens Mahidol University
Konstantin Chumakov
Konstantin Chumakov US Food and Drug Administration

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a Microbiology degree can open doors to various health and science-related careers. For those interested in public health, exploring online MPH programs easy to get into offers a practical pathway. These programs provide foundational knowledge in epidemiology and health policy, complementing microbiology expertise.

Additionally, students passionate about supporting others may consider becoming a child life specialist. This role focuses on helping children cope with medical experiences, blending healthcare with emotional support—a meaningful career intersection for microbiology graduates.

Applicants with diverse backgrounds will find promising options too. For instance, individuals looking for online colleges that accept felons can still pursue higher education and launch new career paths. Many accredited programs welcome a wide range of students and offer flexibility through online learning.

Moreover, those drawn to holistic healthcare can explore how to become a functional medicine nurse. This career blends traditional nursing with integrative medicine, making it an appealing option for microbiologists seeking hands-on clinical roles.

Best Scientists Citing John F. Modlin

Trending Scientists

Recently Published Articles